首页 > 最新文献

Pediatric Respirology and Critical Care Medicine最新文献

英文 中文
Spontaneous pneumomediastinum in children 儿童自发性纵隔气肿
Pub Date : 2021-07-01 DOI: 10.4103/prcm.prcm_13_21
Yen-Jhih Liao, Y. Huang, Bao-Ren Nong
Scarce studies about spontaneous pneumomediastinum (SPM) in pediatric patients are published because of lower incidence in a child than an adult. This article is a literature review of pediatric SPM, discussing about aspects of incidence rate, epidemiology, pathophysiology, diagnosis, management, and prognosis about pediatric SPM. In conclusion, SPM is usually a benign disease and treatable with only supportive care. However, poorer prognosis is noted; if it is complicated with other underlying diseases or complications, then aggressive treatment might be needed.
由于儿童自发性纵膈气(SPM)的发病率低于成人,因此关于儿童自发性纵膈气(SPM)的研究很少发表。本文就小儿SPM的发病率、流行病学、病理生理、诊断、治疗及预后等方面进行综述。总之,SPM通常是一种良性疾病,只需支持性护理即可治疗。然而,预后较差;如果合并其他潜在疾病或并发症,则可能需要积极治疗。
{"title":"Spontaneous pneumomediastinum in children","authors":"Yen-Jhih Liao, Y. Huang, Bao-Ren Nong","doi":"10.4103/prcm.prcm_13_21","DOIUrl":"https://doi.org/10.4103/prcm.prcm_13_21","url":null,"abstract":"Scarce studies about spontaneous pneumomediastinum (SPM) in pediatric patients are published because of lower incidence in a child than an adult. This article is a literature review of pediatric SPM, discussing about aspects of incidence rate, epidemiology, pathophysiology, diagnosis, management, and prognosis about pediatric SPM. In conclusion, SPM is usually a benign disease and treatable with only supportive care. However, poorer prognosis is noted; if it is complicated with other underlying diseases or complications, then aggressive treatment might be needed.","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129901012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mouth breathing during sleep and persistence of OSA after adeno-tonsillectomy in non-obese children 非肥胖儿童腺扁桃体切除术后睡眠时的口呼吸与阻塞性睡眠呼吸暂停的持续
Pub Date : 2021-07-01 DOI: 10.4103/prcm.prcm_17_21
Brigitte Fung, Mei-yee Lau, Shuk-yu Leung, R. Wong, K. Kwok, D. Ng
Objective: To evaluate the relationship between the percentage of total sleep time with mouth breathing (SMBP) and post-adeno-tonsillectomy apnea-hypopnea index (AHI) in non-obese children. Materials and Methods: Non-obese obstructive sleep apnea (OSA) children with pre- and post- TandA PSG done between August 2011 and February 2019 were reviewed and mouth breathing during sleep was manually scored. Percentage of total sleep time with mouth breathing (SMBP) was calculated. Its correlation with post-operative AHI >1.5/h was studied. Results: Fifty-nine children were included in the analysis and 47 of the study group (79.7%) were male. The mean age at pre-operative PSG was 9.2+/-3.1 years. The mean AHI dropped from 8.3+/-19.8 to 4.1+/-11.6 (P < 0.001). Thirty-one (50.8%) were cured of OSA defined as AHI<=1.5/h. There was a statistically significant positive correlation between post-operative log-transformed AHI and log-transformed SMBP (r=0.265, P = 0.044). The optimal SMBP for detecting residual OSA was 10.5%. The sensitivity, specificity, positive predictive value, negative predictive value and Youden Index were 0.86, 0.37, 0.57, 0.73 and 0.23, respectively. Post-operative children with SMBP >10.5% had higher risk for residual OSA (OR 4.2, 95%CI: 1.2–15.0, P = 0.029). Conclusion: Obstructive sleep apnea children with mouth breathing for more than 10.5% of total sleep time are more likely to have residual OSA after TandA.
目的:探讨非肥胖儿童口腔呼吸总睡眠时间百分比(SMBP)与腺扁桃体切除术后呼吸暂停低通气指数(AHI)的关系。材料和方法:回顾2011年8月至2019年2月期间进行TandA术前和术后PSG的非肥胖阻塞性睡眠呼吸暂停(OSA)儿童,并对睡眠时的口腔呼吸进行人工评分。计算口腔呼吸占总睡眠时间的百分比(SMBP)。研究其与术后AHI >1.5/h的相关性。结果:59例儿童纳入分析,其中47例为男性,占79.7%。术前PSG的平均年龄为9.2±3.1岁。平均AHI由8.3+/-19.8降至4.1+/-11.6 (P < 0.001)。确诊为AHI10.5%的OSA治愈者中有31例(50.8%)存在较高的OSA残留风险(OR 4.2, 95%CI: 1.2 ~ 15.0, P = 0.029)。结论:口腔呼吸时间占总睡眠时间10.5%以上的阻塞性睡眠呼吸暂停患儿TandA术后残留OSA的可能性较大。
{"title":"Mouth breathing during sleep and persistence of OSA after adeno-tonsillectomy in non-obese children","authors":"Brigitte Fung, Mei-yee Lau, Shuk-yu Leung, R. Wong, K. Kwok, D. Ng","doi":"10.4103/prcm.prcm_17_21","DOIUrl":"https://doi.org/10.4103/prcm.prcm_17_21","url":null,"abstract":"Objective: To evaluate the relationship between the percentage of total sleep time with mouth breathing (SMBP) and post-adeno-tonsillectomy apnea-hypopnea index (AHI) in non-obese children. Materials and Methods: Non-obese obstructive sleep apnea (OSA) children with pre- and post- TandA PSG done between August 2011 and February 2019 were reviewed and mouth breathing during sleep was manually scored. Percentage of total sleep time with mouth breathing (SMBP) was calculated. Its correlation with post-operative AHI >1.5/h was studied. Results: Fifty-nine children were included in the analysis and 47 of the study group (79.7%) were male. The mean age at pre-operative PSG was 9.2+/-3.1 years. The mean AHI dropped from 8.3+/-19.8 to 4.1+/-11.6 (P < 0.001). Thirty-one (50.8%) were cured of OSA defined as AHI<=1.5/h. There was a statistically significant positive correlation between post-operative log-transformed AHI and log-transformed SMBP (r=0.265, P = 0.044). The optimal SMBP for detecting residual OSA was 10.5%. The sensitivity, specificity, positive predictive value, negative predictive value and Youden Index were 0.86, 0.37, 0.57, 0.73 and 0.23, respectively. Post-operative children with SMBP >10.5% had higher risk for residual OSA (OR 4.2, 95%CI: 1.2–15.0, P = 0.029). Conclusion: Obstructive sleep apnea children with mouth breathing for more than 10.5% of total sleep time are more likely to have residual OSA after TandA.","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130030505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The last mile of COVID-19? COVID-19的最后一英里?
Pub Date : 2021-07-01 DOI: 10.4103/prcm.prcm_9_22
Yu-Tsun Su
{"title":"The last mile of COVID-19?","authors":"Yu-Tsun Su","doi":"10.4103/prcm.prcm_9_22","DOIUrl":"https://doi.org/10.4103/prcm.prcm_9_22","url":null,"abstract":"","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129971486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beginning of the End 结束的开始
Pub Date : 2021-04-01 DOI: 10.4103/prcm.prcm_8_22
Daniel Ng
{"title":"Beginning of the End","authors":"Daniel Ng","doi":"10.4103/prcm.prcm_8_22","DOIUrl":"https://doi.org/10.4103/prcm.prcm_8_22","url":null,"abstract":"","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126804789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paediatric obstructive sleep apnoea: Pathophysiology and the role of myofunctional therapy 小儿阻塞性睡眠呼吸暂停:病理生理学和肌功能治疗的作用
Pub Date : 2021-04-01 DOI: 10.4103/prcm.prcm_21_21
Yan Li
The pathophysiology of obstructive sleep apnoea (OSA) is well studied in the adult population, but not in the paediatric population, although it can be generally classified into anatomical, functional, and pathological factors, with the most common aetiology being adenotonsillar hypertrophy and a reduced neuromuscular tone of the upper airway (UA) muscles. It is vital to understand the pathophysiology behind paediatric OSA, so that treatment can be optimized. Although the first-line treatment remains to be adenotonsillectomy (AT), this is not always effective, as indicated by the complex pathophysiology of OSA, leading to residual OSA post-AT. Myofunctional therapy (MFT), a newer non-invasive method focusing on re-educating, strengthening, and stimulating UA muscles, improves neuromuscular tone and prevents airway collapse, as supported by multiple randomized controlled trials (RCTs). Outcomes after 2 months to 2 years of therapy have also been positive, with children experiencing improved sleep quality, reduced emotional distress and mood swings, and reduced daytime problems, whereas polysomnogram (PSG) results revealed a clinically significant reduced apnoea–hypopnoea index post-therapy. Major limitations include poor compliance for active MFT and the short duration of the studies with small sample sizes. Given the high prevalence rates of childhood OSA, it is essential that more high-quality studies and RCTs are performed to assess the effectiveness of this treatment method, with a specific emphasis on its long-term impacts, risks, and optimal treatment duration.
阻塞性睡眠呼吸暂停(OSA)的病理生理学在成人人群中得到了很好的研究,但在儿科人群中还没有得到很好的研究,尽管它可以大致分为解剖、功能和病理因素,最常见的病因是腺扁桃体肥大和上呼吸道(UA)肌肉的神经肌肉张力降低。了解小儿阻塞性睡眠呼吸暂停背后的病理生理学是至关重要的,这样才能优化治疗。虽然一线治疗仍然是腺扁桃体切除术(AT),但这并不总是有效的,正如OSA复杂的病理生理所表明的那样,导致AT后残留的OSA。肌功能疗法(MFT)是一种新的非侵入性方法,专注于重新教育,加强和刺激UA肌肉,改善神经肌肉张力,防止气道塌陷,得到多项随机对照试验(rct)的支持。治疗后2个月至2年的结果也是积极的,儿童的睡眠质量得到改善,情绪困扰和情绪波动减少,白天问题减少,而多导睡眠图(PSG)结果显示治疗后呼吸暂停-低通气指数显著降低。主要的限制包括活动性MFT的依从性差,研究时间短,样本量小。鉴于儿童OSA的高患病率,有必要开展更多高质量的研究和随机对照试验来评估这种治疗方法的有效性,并特别强调其长期影响、风险和最佳治疗时间。
{"title":"Paediatric obstructive sleep apnoea: Pathophysiology and the role of myofunctional therapy","authors":"Yan Li","doi":"10.4103/prcm.prcm_21_21","DOIUrl":"https://doi.org/10.4103/prcm.prcm_21_21","url":null,"abstract":"The pathophysiology of obstructive sleep apnoea (OSA) is well studied in the adult population, but not in the paediatric population, although it can be generally classified into anatomical, functional, and pathological factors, with the most common aetiology being adenotonsillar hypertrophy and a reduced neuromuscular tone of the upper airway (UA) muscles. It is vital to understand the pathophysiology behind paediatric OSA, so that treatment can be optimized. Although the first-line treatment remains to be adenotonsillectomy (AT), this is not always effective, as indicated by the complex pathophysiology of OSA, leading to residual OSA post-AT. Myofunctional therapy (MFT), a newer non-invasive method focusing on re-educating, strengthening, and stimulating UA muscles, improves neuromuscular tone and prevents airway collapse, as supported by multiple randomized controlled trials (RCTs). Outcomes after 2 months to 2 years of therapy have also been positive, with children experiencing improved sleep quality, reduced emotional distress and mood swings, and reduced daytime problems, whereas polysomnogram (PSG) results revealed a clinically significant reduced apnoea–hypopnoea index post-therapy. Major limitations include poor compliance for active MFT and the short duration of the studies with small sample sizes. Given the high prevalence rates of childhood OSA, it is essential that more high-quality studies and RCTs are performed to assess the effectiveness of this treatment method, with a specific emphasis on its long-term impacts, risks, and optimal treatment duration.","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122276225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review findings of drug-induced sleep endoscopy (DISE) in children with obstructive sleep apnea (OSA) 阻塞性睡眠呼吸暂停(OSA)患儿药物性睡眠内窥镜检查结果综述
Pub Date : 2021-04-01 DOI: 10.4103/prcm.prcm_5_22
G. Yeung, Shuk-yu Leung, K. Kwok
Background: Drug-induced sleep endoscopy (DISE) is an objective assessment and diagnostic procedure of the upper airway obstruction (UAO) under sedation. Findings of DISE in Hong Kong pediatric group patients with obstructive sleep apnea (OSA) are limited. Materials and Methods: This is a single-center retrospective chart review study on DISE findings in pediatric patients with OSA documented by polysomnography (PSG). We used the DISE scoring system proposed by Chan 2014, Fishman 2013 together as our internal practice. A standard sedation protocol was conducted. Endoscopic findings were recorded and evaluated the level of obstruction, severity, and correlation with PSG parameters. Results: A total of 124 patients who underwent DISE were reviewed in our study. Multiple levels of obstruction had been observed in all patients. Forty-five (36.6%) patients suffered from severe obstruction in more than one level. Tongue base was the most common level being severely obstructed. DISE total score is positively correlated with obstructive apnea-hypopnea index (oAHI, r = 0.35, P = <0.001), negatively correlated with oxygen nadir (SpO2 nadir, r = –0.32, P = <0.001), and positively correlated with desaturation index (DI, r = 0.34, P < 0.001). In the subgroup analysis of the post-adenotonsillectomy (AT) group, scores in nostrils, tongue base, and supraglottic showed significantly increased. None of the subjects had complications from sedation or the endoscopy procedure. Conclusion: In our study, DISE was shown to be a safe, feasible, and informative assessment tool for pediatric OSA patients. In particular, multiple levels of obstruction were common in children and we observed a significant correlation between the severity of UAO measured by DISE in children with OSA and PSG parameters. Changes in UAO sites were observed when preoperative patients underwent surgical treatment.
背景:药物诱导睡眠内镜(Drug-induced sleep endoscopy,简称DISE)是一种对镇静状态下上呼吸道梗阻(UAO)进行客观评估和诊断的方法。DISE在香港儿童组阻塞性睡眠呼吸暂停(OSA)患者中的发现是有限的。材料和方法:这是一项单中心回顾性图表综述研究,通过多导睡眠图(PSG)记录了儿童OSA患者的DISE结果。我们采用了Chan 2014和Fishman 2013共同提出的DISE评分系统作为我们的内部实践。采用标准镇静方案。记录内镜检查结果并评估梗阻程度、严重程度以及与PSG参数的相关性。结果:我们的研究共回顾了124例接受了DISE的患者。所有患者均有不同程度的梗阻。45例(36.6%)患者出现严重的一级以上梗阻。舌根是最常见的严重阻塞水平。DISE总分与阻塞性呼吸暂停低通气指数(oAHI, r = 0.35, P = <0.001)正相关,与氧最低点(SpO2最低点,r = -0.32, P = <0.001)负相关,与去饱和指数(DI, r = 0.34, P <0.001)正相关。在腺扁桃体切除术(AT)组的亚组分析中,鼻孔、舌根和声门上的评分明显增加。所有受试者均未出现镇静或内窥镜检查的并发症。结论:在我们的研究中,DISE被证明是一种安全、可行和信息丰富的儿童OSA患者评估工具。特别是,多种程度的梗阻在儿童中很常见,我们观察到,在患有OSA的儿童中,DISE测量的UAO严重程度与PSG参数之间存在显著相关性。术前患者接受手术治疗时观察到UAO部位的变化。
{"title":"Review findings of drug-induced sleep endoscopy (DISE) in children with obstructive sleep apnea (OSA)","authors":"G. Yeung, Shuk-yu Leung, K. Kwok","doi":"10.4103/prcm.prcm_5_22","DOIUrl":"https://doi.org/10.4103/prcm.prcm_5_22","url":null,"abstract":"Background: Drug-induced sleep endoscopy (DISE) is an objective assessment and diagnostic procedure of the upper airway obstruction (UAO) under sedation. Findings of DISE in Hong Kong pediatric group patients with obstructive sleep apnea (OSA) are limited. Materials and Methods: This is a single-center retrospective chart review study on DISE findings in pediatric patients with OSA documented by polysomnography (PSG). We used the DISE scoring system proposed by Chan 2014, Fishman 2013 together as our internal practice. A standard sedation protocol was conducted. Endoscopic findings were recorded and evaluated the level of obstruction, severity, and correlation with PSG parameters. Results: A total of 124 patients who underwent DISE were reviewed in our study. Multiple levels of obstruction had been observed in all patients. Forty-five (36.6%) patients suffered from severe obstruction in more than one level. Tongue base was the most common level being severely obstructed. DISE total score is positively correlated with obstructive apnea-hypopnea index (oAHI, r = 0.35, P = <0.001), negatively correlated with oxygen nadir (SpO2 nadir, r = –0.32, P = <0.001), and positively correlated with desaturation index (DI, r = 0.34, P < 0.001). In the subgroup analysis of the post-adenotonsillectomy (AT) group, scores in nostrils, tongue base, and supraglottic showed significantly increased. None of the subjects had complications from sedation or the endoscopy procedure. Conclusion: In our study, DISE was shown to be a safe, feasible, and informative assessment tool for pediatric OSA patients. In particular, multiple levels of obstruction were common in children and we observed a significant correlation between the severity of UAO measured by DISE in children with OSA and PSG parameters. Changes in UAO sites were observed when preoperative patients underwent surgical treatment.","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125230792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-flow Nasal Cannula in Pediatric Patients 儿科患者的高流量鼻插管
Pub Date : 2021-04-01 DOI: 10.4103/prcm.prcm_1_21
N. Puspaningtyas, R. Dewi, A. Pudjiadi
High-flow nasal cannula (HFNC) provides conditioned high-flow oxygen through an open system with high pressure and high velocity. HFNC has been widely used in neonatal patients with comparable benefit to CPAP; however, the use in pediatric patients has not been well evaluated. In pediatric patients, a regular nasal cannula is widely used as oxygen therapy, but the flow provided is limited because the humidity is not optimal. While HFNC as noninvasive oxygen therapy can deliver heated, humidified gas, via nasal cannula. High-velocity HFNC makes oxygen-rich gases occupy the dead space of the nasopharynx, increasing FiO2, and improving alveolar ventilation. The use of HFNC in children begins with bronchiolitis patients, also considered effective in various respiratory disorders including cases of hypoxemic respiratory failure. HFNC has been shown to have a better patient tolerance, less nose damage, and less work for the staff than CPAP and noninvasive ventilators (NIV). HFNC can be used in the emergency department and even the patient ward, while CPAP and NIV require intensive care unit facility as it needs close monitoring. HFNC is considered safe with mild side effects such as epistaxis and skin irritation that have been reported. While serious side effects such as pneumothorax are rarely reported because open system HFNC can prevent a sudden increase in airway pressure.
高流量鼻插管(HFNC)通过一个开放的高压高速系统提供有条件的高流量氧气。HFNC已被广泛应用于新生儿患者,其获益与CPAP相当;然而,在儿科患者中的使用尚未得到很好的评价。在儿科患者中,常规鼻插管被广泛用于氧气治疗,但由于湿度不理想,提供的流量有限。而HFNC作为无创氧疗,可以通过鼻导管输送加热的湿化气体。高速HFNC使富氧气体占据鼻咽部的死腔,增加FiO2,改善肺泡通气。HFNC在儿童中的应用始于细支气管炎患者,也被认为对各种呼吸系统疾病有效,包括低氧性呼吸衰竭病例。与CPAP和无创呼吸机(NIV)相比,HFNC具有更好的患者耐受性,更少的鼻子损伤,工作人员的工作量更少。HFNC可以在急诊科甚至病人病房使用,而CPAP和NIV需要密切监测,需要重症监护病房设施。HFNC被认为是安全的,有轻微的副作用,如鼻出血和皮肤刺激。虽然严重的副作用,如气胸很少报道,因为开放系统HFNC可以防止气道压力突然增加。
{"title":"High-flow Nasal Cannula in Pediatric Patients","authors":"N. Puspaningtyas, R. Dewi, A. Pudjiadi","doi":"10.4103/prcm.prcm_1_21","DOIUrl":"https://doi.org/10.4103/prcm.prcm_1_21","url":null,"abstract":"High-flow nasal cannula (HFNC) provides conditioned high-flow oxygen through an open system with high pressure and high velocity. HFNC has been widely used in neonatal patients with comparable benefit to CPAP; however, the use in pediatric patients has not been well evaluated. In pediatric patients, a regular nasal cannula is widely used as oxygen therapy, but the flow provided is limited because the humidity is not optimal. While HFNC as noninvasive oxygen therapy can deliver heated, humidified gas, via nasal cannula. High-velocity HFNC makes oxygen-rich gases occupy the dead space of the nasopharynx, increasing FiO2, and improving alveolar ventilation. The use of HFNC in children begins with bronchiolitis patients, also considered effective in various respiratory disorders including cases of hypoxemic respiratory failure. HFNC has been shown to have a better patient tolerance, less nose damage, and less work for the staff than CPAP and noninvasive ventilators (NIV). HFNC can be used in the emergency department and even the patient ward, while CPAP and NIV require intensive care unit facility as it needs close monitoring. HFNC is considered safe with mild side effects such as epistaxis and skin irritation that have been reported. While serious side effects such as pneumothorax are rarely reported because open system HFNC can prevent a sudden increase in airway pressure.","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133979123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications of COVID-19 in children and the approach to the affected children in pediatric primary care 儿童COVID-19并发症及儿科初级保健中受影响儿童的处理方法
Pub Date : 2021-01-01 DOI: 10.4103/prcm.prcm_15_21
P. Pohunek
Pandemics of the coronavirus SARS-Cov-2 has been circulating the world since the beginning of 2020 in several waves leaving behind many millions of affected individuals and very many fatalities. In children, the course of the disease has generally been milder that in adults; however, there was a wide range of possible serious complications observed including the pediatric fatalities. In this article, we review possible complications of COVID-19 in children and also focus on the role of pediatric primary care practitioners in the diagnosis and management of this serious disease.
自2020年初以来,冠状病毒SARS-Cov-2大流行在世界各地分几波传播,造成数百万人受影响,并造成许多人死亡。儿童的病程一般较成人轻;然而,观察到各种可能的严重并发症,包括儿童死亡。在本文中,我们回顾了COVID-19在儿童中可能出现的并发症,并重点介绍了儿科初级保健医生在这一严重疾病的诊断和管理中的作用。
{"title":"Complications of COVID-19 in children and the approach to the affected children in pediatric primary care","authors":"P. Pohunek","doi":"10.4103/prcm.prcm_15_21","DOIUrl":"https://doi.org/10.4103/prcm.prcm_15_21","url":null,"abstract":"Pandemics of the coronavirus SARS-Cov-2 has been circulating the world since the beginning of 2020 in several waves leaving behind many millions of affected individuals and very many fatalities. In children, the course of the disease has generally been milder that in adults; however, there was a wide range of possible serious complications observed including the pediatric fatalities. In this article, we review possible complications of COVID-19 in children and also focus on the role of pediatric primary care practitioners in the diagnosis and management of this serious disease.","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114873382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
After COVID - where now? COVID之后,现在在哪里?
Pub Date : 2021-01-01 DOI: 10.4103/prcm.prcm_14_21
Andrew Bush
{"title":"After COVID - where now?","authors":"Andrew Bush","doi":"10.4103/prcm.prcm_14_21","DOIUrl":"https://doi.org/10.4103/prcm.prcm_14_21","url":null,"abstract":"","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"41 5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128220174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To help the Fight 帮助战斗
Pub Date : 2021-01-01 DOI: 10.4103/prcm.prcm_20_21
Daniel Ng
{"title":"To help the Fight","authors":"Daniel Ng","doi":"10.4103/prcm.prcm_20_21","DOIUrl":"https://doi.org/10.4103/prcm.prcm_20_21","url":null,"abstract":"","PeriodicalId":273845,"journal":{"name":"Pediatric Respirology and Critical Care Medicine","volume":"81 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125176168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric Respirology and Critical Care Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1